BALAXI PHARMACEUTICALS
|
BALAXI PHARMACEUTICALS Last 5 Year Income Statement History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
INCOME : | |||||
Gross Sales | ₹279 Cr | ₹231 Cr | ₹46 Cr | ₹1,360 Cr | ₹14 Cr |
Sales | ₹279 Cr | ₹231 Cr | ₹46 Cr | ₹1,360 Cr | ₹14 Cr |
Job Work/ Contract Receipts | - | - | - | - | - |
Processing Charges / Service Income | - | - | - | - | - |
Revenue from property development | - | - | - | - | - |
Other Operational Income | - | - | - | - | - |
Less: Excise Duty | - | - | - | - | - |
Net Sales | ₹279 Cr | ₹231 Cr | ₹46 Cr | ₹1,360 Cr | ₹14 Cr |
EXPENDITURE : | |||||
Increase/Decrease in Stock | - | - | - | - | - |
Raw Material Consumed | ₹196 Cr | ₹172 Cr | ₹33 Cr | ₹1,024 Cr | ₹10 Cr |
Opening Raw Materials | - | - | - | - | - |
Purchases Raw Materials | - | - | - | - | - |
Closing Raw Materials | - | - | - | - | - |
Other Direct Purchases / Brought in cost | - | - | - | - | - |
Other raw material cost | ₹196 Cr | ₹172 Cr | ₹33 Cr | ₹1,024 Cr | ₹10 Cr |
Power & Fuel Cost | ₹0.35 Cr | - | - | - | - |
Electricity & Power | ₹0.35 Cr | - | - | - | - |
Oil, Fuel & Natural gas | - | - | - | - | - |
Coals etc | - | - | - | - | - |
Other power & fuel | - | - | - | - | - |
Employee Cost | ₹12 Cr | ₹8.47 Cr | ₹2.10 Cr | ₹90 Cr | ₹0.90 Cr |
Salaries, Wages & Bonus | ₹12 Cr | ₹8.33 Cr | ₹2.00 Cr | ₹90 Cr | ₹0.90 Cr |
Contributions to EPF & Pension Funds | - | - | - | - | - |
Workmen and Staff Welfare Expenses | ₹0.22 Cr | ₹0.14 Cr | ₹0.10 Cr | - | - |
Other Employees Cost | - | - | - | - | - |
Other Manufacturing Expenses | - | - | - | - | - |
Sub-contracted / Out sourced services | - | - | - | - | - |
Processing Charges | - | - | - | - | - |
Repairs and Maintenance | - | - | - | - | - |
Packing Material Consumed | - | - | - | - | - |
Other Mfg Exp | - | - | - | - | - |
General and Administration Expenses | ₹15 Cr | ₹5.28 Cr | ₹2.34 Cr | ₹61 Cr | ₹0.61 Cr |
Rent , Rates & Taxes | ₹3.49 Cr | ₹1.21 Cr | ₹0.26 Cr | ₹12 Cr | ₹0.12 Cr |
Insurance | ₹0.21 Cr | - | - | ₹0.70 Cr | ₹0.01 Cr |
Printing and stationery | ₹0.52 Cr | ₹0.24 Cr | ₹0.16 Cr | ₹2.75 Cr | ₹0.03 Cr |
Professional and legal fees | ₹3.01 Cr | ₹1.25 Cr | ₹0.19 Cr | ₹9.34 Cr | ₹0.09 Cr |
Traveling and conveyance | ₹4.23 Cr | ₹0.80 Cr | ₹0.45 Cr | ₹8.37 Cr | ₹0.08 Cr |
Other Administration | ₹7.75 Cr | ₹2.59 Cr | ₹1.72 Cr | ₹36 Cr | ₹0.36 Cr |
Selling and Distribution Expenses | ₹1.02 Cr | ₹0.10 Cr | ₹0.10 Cr | ₹21 Cr | ₹0.21 Cr |
Advertisement & Sales Promotion | ₹1.02 Cr | ₹0.10 Cr | ₹0.10 Cr | ₹1.54 Cr | ₹0.02 Cr |
Sales Commissions & Incentives | - | - | - | - | - |
Freight and Forwarding | - | - | - | ₹20 Cr | ₹0.20 Cr |
Handling and Clearing Charges | - | - | - | - | - |
Other Selling Expenses | - | - | - | - | - |
Miscellaneous Expenses | ₹4.16 Cr | ₹2.65 Cr | ₹0.02 Cr | ₹7.88 Cr | ₹0.08 Cr |
Bad debts /advances written off | - | ₹0.04 Cr | - | - | - |
Provision for doubtful debts | - | - | - | - | - |
Losson disposal of fixed assets(net) | - | - | - | - | - |
Losson foreign exchange fluctuations | - | - | - | ₹7.77 Cr | ₹0.08 Cr |
Losson sale of non-trade current investments | - | - | - | ₹0.11 Cr | ₹0.00 Cr |
Other Miscellaneous Expenses | ₹4.16 Cr | ₹2.62 Cr | ₹0.02 Cr | - | - |
Less: Expenses Capitalised | - | - | - | - | - |
Total Expenditure | ₹229 Cr | ₹189 Cr | ₹37 Cr | ₹1,204 Cr | ₹12 Cr |
Operating Profit (Excl OI) | ₹51 Cr | ₹43 Cr | ₹8.25 Cr | ₹156 Cr | ₹1.56 Cr |
Other Income | ₹4.97 Cr | ₹2.23 Cr | ₹0.60 Cr | ₹89 Cr | ₹0.89 Cr |
Interest Received | - | ₹0.00 Cr | - | - | - |
Dividend Received | - | - | - | - | - |
Profit on sale of Fixed Assets | - | - | - | - | - |
Profits on sale of Investments | - | - | - | - | - |
Provision Written Back | - | - | - | - | - |
Foreign Exchange Gains | ₹4.94 Cr | ₹2.05 Cr | ₹0.56 Cr | - | - |
Others | ₹0.03 Cr | ₹0.18 Cr | ₹0.03 Cr | ₹89 Cr | ₹0.89 Cr |
Operating Profit | ₹56 Cr | ₹45 Cr | ₹8.85 Cr | ₹245 Cr | ₹2.45 Cr |
Interest | ₹0.76 Cr | ₹0.28 Cr | ₹0.05 Cr | ₹0.23 Cr | ₹0.00 Cr |
InterestonDebenture / Bonds | - | - | - | - | - |
Interest on Term Loan | - | - | - | - | - |
Intereston Fixed deposits | - | - | - | - | - |
Bank Charges etc | ₹0.62 Cr | ₹0.26 Cr | ₹0.05 Cr | ₹0.23 Cr | ₹0.00 Cr |
Other Interest | ₹0.14 Cr | ₹0.02 Cr | - | - | - |
PBDT | ₹55 Cr | ₹45 Cr | ₹8.80 Cr | ₹244 Cr | ₹2.44 Cr |
Depreciation | ₹0.51 Cr | ₹0.30 Cr | ₹0.01 Cr | ₹0.35 Cr | ₹0.00 Cr |
Profit Before Taxation & Exceptional Items | ₹55 Cr | ₹44 Cr | ₹8.79 Cr | ₹244 Cr | ₹2.44 Cr |
Exceptional Income / Expenses | - | - | - | - | - |
Profit Before Tax | ₹55 Cr | ₹44 Cr | ₹8.79 Cr | ₹244 Cr | ₹2.44 Cr |
Provision for Tax | ₹6.87 Cr | ₹6.19 Cr | ₹2.69 Cr | ₹47 Cr | ₹0.47 Cr |
Current Income Tax | ₹6.83 Cr | ₹6.19 Cr | ₹2.69 Cr | ₹47 Cr | ₹0.47 Cr |
Deferred Tax | ₹0.03 Cr | ₹0.00 Cr | ₹0.00 Cr | - | - |
Other taxes | - | - | - | ₹47 Cr | ₹0.47 Cr |
Profit After Tax | ₹48 Cr | ₹38 Cr | ₹6.10 Cr | ₹197 Cr | ₹1.97 Cr |
Extra items | - | - | ₹0.03 Cr | - | - |
Minority Interest | - | - | - | - | - |
Share of Associate | - | - | - | - | - |
Other Consolidated Items | ₹0.53 Cr | ₹-0.90 Cr | - | - | - |
Consolidated Net Profit | ₹48 Cr | ₹37 Cr | ₹6.13 Cr | ₹197 Cr | ₹1.97 Cr |
Adjustments to PAT | - | - | - | - | - |
Profit Balance B/F | ₹44 Cr | ₹6.45 Cr | ₹0.32 Cr | ₹-165 Cr | ₹-1.65 Cr |
Appropriations | ₹92 Cr | ₹44 Cr | ₹6.45 Cr | ₹32 Cr | ₹0.32 Cr |
General Reserves | - | - | - | - | - |
Proposed Equity Dividend | - | - | - | - | - |
Corporate dividend tax | - | - | - | - | - |
Other Appropriation | - | - | - | - | - |
Equity Dividend % | ₹5.00 | - | - | - | - |
Earnings Per Share | ₹48.18 | ₹37.23 | ₹6.10 | ₹6.47 | ₹6.47 |
Adjusted EPS | ₹48.18 | ₹37.23 | ₹6.10 | ₹6.47 | ₹6.47 |
Compare Income Statement of peers of BALAXI PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BALAXI PHARMACEUTICALS | ₹663.1 Cr | 4.8% | 21.5% | 15.7% | Stock Analytics | |
ADANI ENTERPRISES | ₹346,235.0 Cr | -2.5% | -4.9% | 64.9% | Stock Analytics | |
REDINGTON | ₹17,070.0 Cr | -2.2% | 4.9% | 31.7% | Stock Analytics | |
HONASA CONSUMER | ₹13,767.4 Cr | 0.4% | 5.6% | NA | Stock Analytics | |
MMTC | ₹11,232.0 Cr | 0.3% | 12.8% | 132.7% | Stock Analytics | |
MSTC | ₹6,278.6 Cr | -3.9% | 7.3% | 203.5% | Stock Analytics |
BALAXI PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BALAXI PHARMACEUTICALS | 4.8% |
21.5% |
15.7% |
SENSEX | 1% |
2.2% |
23.7% |
You may also like the below Video Courses